Prelude Therapeutics Inc (PRLD) Dividends

Dividend Overview

Dividend Yield

—

Dividend / Share

—

Key Metrics

Market Cap

$297.98M

P/E Ratio

-2.99

Forward P/E

—

EPS

$-1.29

PEG Ratio

0.06

Book Value

$1.09

Dividend Yield

—

Profit Margin

-819.59%

ROE

-144.96%

Dividend History

Dividend Safety

PRLD Dividend Analysis

Prelude Therapeutics Inc (PRLD) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -2.99. Profit margin: -819.59%. Free cash flow: $-56.37M. This page shows Prelude Therapeutics Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Prelude Therapeutics Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.